The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition
about
Plant-associated symbiotic Burkholderia species lack hallmark strategies required in mammalian pathogenesisBurkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation.Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis.Characterization of the mrgRS locus of the opportunistic pathogen Burkholderia pseudomallei: temperature regulates the expression of a two-component signal transduction systemATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei.Survival of Burkholderia pseudomallei in water.Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei.Comparative genomics of the emerging human pathogen Photorhabdus asymbiotica with the insect pathogen Photorhabdus luminescensA Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.Present and future therapeutic strategies for melioidosis and glanders.A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent listsDelineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophagesGenomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates.Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophilsEvidence for a role of the polysaccharide capsule transport proteins in pertussis pathogenesis.Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosisMultilocus sequence typing of historical Burkholderia pseudomallei isolates collected in Southeast Asia from 1964 to 1967 provides insight into the epidemiology of melioidosisRole of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance.Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.Mutations of the quorum sensing-dependent regulator VjbR lead to drastic surface modifications in Brucella melitensis.Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.Burkholderia pseudomallei Differentially Regulates Host Innate Immune Response Genes for Intracellular Survival in Lung Epithelial CellsDevelopment of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glandersSerodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives.Comprehensive identification of virulence factors required for respiratory melioidosis using Tn-seq mutagenesisTwo stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling.Development of novel O-polysaccharide based glycoconjugates for immunization against glandersRole of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis.Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infectionContribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.
P2860
Q30731722-4B159E9F-55D5-449B-A2FE-02D8905C8A08Q30803004-EC3CEA0D-D0F9-4D26-AE56-D18D155323B2Q33244722-1DAC60D0-034A-49C2-9306-184882595116Q33253132-4EA8E8CF-40FB-4001-B7BF-C763BCF6BB5FQ33280317-7CF2EBF3-2D32-4395-959F-9948BE6AEC57Q33360998-817DE76A-5BA1-4EA7-B903-27F871C281EFQ33372589-85CEE971-BFAC-4764-80CD-5BAD0B0B30F8Q33479324-7CF37E06-09EC-4E5A-BE51-22F32D25FBC0Q33601907-5D6AB1A8-107F-4D4D-B402-26F9FA92DB8DQ33709714-F4B2C364-9A44-488B-8CD0-50F1959FEDCDQ33797791-6BB4859B-F0D6-49FE-95E8-12D175868009Q33963058-BD458D67-AF76-4842-98DD-20E966838A61Q34075114-031731B3-8E81-4CD6-986B-C3CAF9A5466CQ34156158-CA03E9D5-097F-4345-A035-3A4DDC82325BQ34243707-5524C87C-8F2D-4119-8B53-5A273C5E73DDQ34517713-A98FF2E4-E0BB-4B58-982A-C2F067A6E834Q34690759-7CD8D170-A018-4467-A8D2-30C02711243DQ34875425-35EF6395-6522-432E-B37C-21E146DBAB43Q35073112-ADDABD8D-EDB0-458B-AC67-D475870D3211Q35217529-C0BF5180-6527-4708-AFEF-99CE02D924BEQ35242077-2B217610-6462-4FC6-A7E3-5188BC16C767Q35689501-23CBE55B-9225-4A98-A90A-EC68DF982EB7Q35805361-DFC1C829-C7CF-443F-B476-B65200AF82F3Q35880149-A42929F4-5714-4F95-BA08-1D4A7E3415C4Q35947308-299CDF74-2F20-4AE1-A264-2FE2BD06B712Q35949935-FC85F764-3F88-4B5B-BFDE-644D2047BA49Q35987326-B4BA8ADC-13C6-41DA-ACC8-1B232CC93E58Q36066110-6CB782D5-B4AB-408C-8ABA-A4162F674A06Q36164961-511E0122-E5AE-4881-989B-5996B73819F7Q36237621-B234E318-A12A-49D5-9F22-6F2EAE09D52EQ36245628-9AB987DF-33FC-4691-843A-448529277B78Q36277130-4E2C5FAA-9C16-4EDB-B3EA-68C1877BE5EAQ36357954-13084E97-C009-493E-B32C-3EB0EEED5D47Q36424795-0404CE5C-4E76-4BCE-874C-303D7EE889F5Q36861793-83E514A7-186E-4937-BA7E-233D7D79B5E8Q37033064-87E1F430-C527-4B7D-A139-DBA1C7EF6F21Q37073972-59FE3317-4988-4361-BF49-345E9665B7E1Q37074494-FD0917B8-6389-4DF8-BD74-F7C82F2BF3C7Q37189868-2964FAB3-BC17-4597-81A9-3F1B13D6C663Q37319232-053BBBB1-88A4-4BAE-B64A-F3991D7056F5
P2860
The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The capsular polysaccharide of ...... mplement factor C3b deposition
@ast
The capsular polysaccharide of ...... mplement factor C3b deposition
@en
type
label
The capsular polysaccharide of ...... mplement factor C3b deposition
@ast
The capsular polysaccharide of ...... mplement factor C3b deposition
@en
prefLabel
The capsular polysaccharide of ...... mplement factor C3b deposition
@ast
The capsular polysaccharide of ...... mplement factor C3b deposition
@en
P2093
P2860
P1476
The capsular polysaccharide of ...... mplement factor C3b deposition
@en
P2093
Donald E Woods
Rebekah DeVinney
Shauna L Reckseidler-Zenteno
P2860
P304
P356
10.1128/IAI.73.2.1106-1115.2005
P407
P577
2005-02-01T00:00:00Z